Monitoring serum IL-18 levels is useful for treatment of a patient with systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
Monitoring serum IL-18 levels is useful for treatment of a patient with systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
复制标题
DOI:
10.1186/1546-0096-9-15
复制
发表时间:
2011-07-13
期刊:
影响因子:
--
通讯作者:
Agematsu K
中科院分区:
文献类型:
--
作者:
Shigemura T;Yamazaki T;Hara Y;Ou JN;Stevens AM;Ochs HD;Koike K;Agematsu K
Systemic juvenile idiopathic arthritis (sJIA) is a systemic inflammatory disease characterized by arthritis, spiking fever and a skin rash that is frequently complicated by macrophage activation syndrome (MAS), a life-threatening disorder. We report a 22-month-old girl with sJIA who developed severe MAS but was successfully treated with corticosteroids, cyclosporin A, and non-steroidal anti-inflammatory drugs by monitoring serum IL-18 levels. IL-18 is an extremely useful cytokine for monitoring the activity of sJIA and MAS, and serum IL-18 can be used as an indicator for the effectiveness of treatment and the decision to discontinue therapy.
登录
查看更多内容
影响因子:
5.1
作者:
Ravelli, A;Magni-Manzoni, S;Martini, A
通讯作者:
Martini, A
影响因子:
4.9
作者:
Woo, P;Wilkinson, N;Kishimoto, T
通讯作者:
Kishimoto, T
影响因子:
5.5
作者:
Shimizu, Masaki;Yokoyama, Tadafumi;Yachie, Akihiro
通讯作者:
Yachie, Akihiro
影响因子:
5.2
作者:
Sawhney, S;Woo, P;Murray, KJ
通讯作者:
Murray, KJ
影响因子:
--
作者:
Bleesing, Jack;Prada, Anne;Grom, Alexei A.
通讯作者:
Grom, Alexei A.